For Japanese

REMUDY is a Japanese registry that serves as a bridge between patients and researchers or business

  • About of REMUDY

 Over recent years there have been large
 progress in the basic study of neuromuscular
 diseases including muscular dystrophy, and
 clinical trials for new therapeutic strategies
 are currently being planned.

 At the final stage of the study, it is necessary
 for safety and effectiveness of these
 therapeutic methods to be confirmed
 by clinical trials in order to determine
 standard therapeutic approaches.
                     
 The patient registry helps planning of
 clinical trials.

 REMUDY(Registry of Muscular Dystrophy)
 is the registry that serves as a bridge between
 patients, researchers, industry, and regulatory agencies.
  プロジェクトのご案内   
  • FIGURES

   Number of registration
     ・ Dystrophinopathy   ・ DMRV
     ・ Myotonic Dystrophy   ・ Congenital

   Registration by prefecture
     ・ Dystrophinopathy   ・ DMRV
     ・ Myotonic Dystrophy   ・ Congenital

   Registration by type of diseases and by age
     ・ Dystrophinopathy   ・ DMRV
     ・ Myotonic Dystrophy

   Others
     ・ Dystrophinopathy   ・ DMRV
     ・ Myotonic Dystrophy